VMVAX | VVJEX | VMVAX / VVJEX | |
Total Expense Ratio | 0.07 | 0.12 | 58% |
Annual Report Gross Expense Ratio | 0.07 | 0.12 | 58% |
Fund Existence | 14 years | 2 years | - |
Gain YTD | 5.592 | 3.537 | 158% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31B | 118M | 26,271% |
Annual Yield % from dividends | 2.22 | 1.75 | 127% |
Returns for 1 year | 8.08 | -2.29 | -352% |
Returns for 3 years | 17.95 | N/A | - |
Returns for 5 years | 65.77 | N/A | - |
Returns for 10 years | 88.57 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDIV | 39.06 | 0.14 | +0.36% |
SPDR® S&P Emerging Markets Dividend ETF | |||
FCEF | 22.61 | 0.04 | +0.16% |
First Trust Income Opportunity ETF | |||
GDIV | 15.76 | N/A | +0.02% |
Harbor Dividend Growth Leaders ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF | |||
VV | 297.02 | -0.64 | -0.22% |
Vanguard Large-Cap ETF |